Skip to content

Beta Bionics, Inc.

BBNX · XNAS

CIK 1674632fmd_07H1Y5VG7D9FMC75T3FS1M6JWDManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Jan 01, 2023 to Sep 30, 2026, 12 periods

Loading

Latest annual · FY2025

Millions
Free cash flow
(56)

Latest quarter · Q3 FY2026

Millions
Free cash flow
(15)
Open Financials

Beta Bionics, Inc. (BBNX) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$100.3 million$65.1 million+53.9%10-K 2026-02-24 · proof
Gross profit$55.5 million$35.9 million+54.8%10-K 2026-02-24 · proof
Operating income-$71.7 million-$45.3 million10-K 2026-02-24 · proof
Net income-$73.2 million-$54.8 million10-K 2026-02-24 · proof
Cash from operating activities-$50.9 million-$48.3 million10-K 2026-02-24 · proof
Free cash flow-$56.2 million-$51.7 million10-K 2026-02-24 · proof
Total assets$328.7 million$149.6 million+119.7%10-K 2026-02-24 · proof
Total liabilities$41.1 million$73.6 million-44.1%10-K 2026-02-24 · proof
Cash and cash equivalents$31.6 million$30.4 million+3.8%10-K 2026-02-24 · proof
What was Beta Bionics, Inc. (BBNX)'s revenue in fiscal 2025?
Beta Bionics, Inc. (BBNX) reported revenue of $100.3 million for fiscal 2025 (the year ended Dec 31, 2025), against $65.1 million the year before (+53.9%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was Beta Bionics, Inc. (BBNX)'s gross profit in fiscal 2025?
Beta Bionics, Inc. (BBNX) reported gross profit of $55.5 million for fiscal 2025 (the year ended Dec 31, 2025), against $35.9 million the year before (+54.8%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was Beta Bionics, Inc. (BBNX)'s operating income in fiscal 2025?
Beta Bionics, Inc. (BBNX) reported operating income of -$71.7 million for fiscal 2025 (the year ended Dec 31, 2025), against -$45.3 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was Beta Bionics, Inc. (BBNX)'s net income in fiscal 2025?
Beta Bionics, Inc. (BBNX) reported net income of -$73.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$54.8 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was Beta Bionics, Inc. (BBNX)'s cash from operating activities in fiscal 2025?
Beta Bionics, Inc. (BBNX) reported cash from operating activities of -$50.9 million for fiscal 2025 (the year ended Dec 31, 2025), against -$48.3 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What was Beta Bionics, Inc. (BBNX)'s free cash flow in fiscal 2025?
Beta Bionics, Inc. (BBNX) reported free cash flow of -$56.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$51.7 million the year before. Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What are Beta Bionics, Inc. (BBNX)'s total assets?
As of Dec 31, 2025, Beta Bionics, Inc. (BBNX) reported total assets of $328.7 million, against $149.6 million a year earlier (+119.7%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What are Beta Bionics, Inc. (BBNX)'s total liabilities?
As of Dec 31, 2025, Beta Bionics, Inc. (BBNX) reported total liabilities of $41.1 million, against $73.6 million a year earlier (-44.1%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC
What are Beta Bionics, Inc. (BBNX)'s cash and cash equivalents?
As of Dec 31, 2025, Beta Bionics, Inc. (BBNX) reported cash and cash equivalents of $31.6 million, against $30.4 million a year earlier (+3.8%). Source: the 10-K filed with the SEC on Feb 24, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BBNX&period_type=annual&limit=5"

Information only, not investment advice.